Yasumichi Inoue

2.3k total citations
56 papers, 1.8k citations indexed

About

Yasumichi Inoue is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yasumichi Inoue has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 19 papers in Oncology and 12 papers in Cell Biology. Recurrent topics in Yasumichi Inoue's work include Ubiquitin and proteasome pathways (11 papers), Cancer-related Molecular Pathways (11 papers) and TGF-β signaling in diseases (9 papers). Yasumichi Inoue is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Cancer-related Molecular Pathways (11 papers) and TGF-β signaling in diseases (9 papers). Yasumichi Inoue collaborates with scholars based in Japan, United States and Canada. Yasumichi Inoue's co-authors include Takeshi Imamura, Hidetoshi Hayashi, Yoichi Taya, Kikuo Onozaki, Atsuhiko Hikita, Masatoshi Kitagawa, Yuka Itoh, Nobumichi Ohoka, Keiji Miyazawa and Akira Hakuba and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Yasumichi Inoue

52 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yasumichi Inoue Japan	22	1.2k	544	305	207	193	56	1.8k
Chun‐Ping Cui China	24	1.2k 1.0×	338 0.6×	426 1.4×	210 1.0×	142 0.7×	61	1.7k
Roland Kappler Germany	29	1.6k 1.3×	431 0.8×	399 1.3×	231 1.1×	110 0.6×	96	2.4k
Levi J. Beverly United States	28	1.7k 1.4×	601 1.1×	403 1.3×	153 0.7×	277 1.4×	65	2.7k
Lin Pei United States	24	1.3k 1.1×	488 0.9×	478 1.6×	251 1.2×	226 1.2×	48	2.6k
David R. Emlet United States	16	1.3k 1.1×	598 1.1×	231 0.8×	99 0.5×	234 1.2×	24	2.1k
Esther Bertrán Spain	24	1.5k 1.2×	681 1.3×	473 1.6×	284 1.4×	195 1.0×	43	2.3k
Helena Jernberg‐Wiklund Sweden	26	1.3k 1.1×	556 1.0×	255 0.8×	113 0.5×	88 0.5×	60	2.0k
Francesco Trapasso Italy	26	1.5k 1.2×	375 0.7×	312 1.0×	103 0.5×	179 0.9×	74	2.0k
Wei Ding China	22	935 0.8×	323 0.6×	198 0.6×	129 0.6×	139 0.7×	66	1.6k
Youn‐Sang Jung South Korea	21	839 0.7×	309 0.6×	228 0.7×	130 0.6×	93 0.5×	42	1.4k

Countries citing papers authored by Yasumichi Inoue

Since Specialization

Citations

This map shows the geographic impact of Yasumichi Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasumichi Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasumichi Inoue more than expected).

Fields of papers citing papers by Yasumichi Inoue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasumichi Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasumichi Inoue. The network helps show where Yasumichi Inoue may publish in the future.

Co-authorship network of co-authors of Yasumichi Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Yasumichi Inoue. A scholar is included among the top collaborators of Yasumichi Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasumichi Inoue. Yasumichi Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Umezawa, Naoki, et al.. (2025). Polyethylene glycol incorporation to reduce the cytotoxicity associated with cationic cell-penetrating-peptide conjugation. RSC Medicinal Chemistry. 16(10). 5025–5031. 1 indexed citations

Wada, Noriaki, Satoshi Sakai, Yasumichi Inoue, & Makoto Nishizuka. (2025). Silencing of fibronectin type III domain-containing protein 3A (FNDC3A) attenuates epithelial-to-mesenchymal transition (EMT), cancer invasion, and stemness in triple-negative breast cancer (TNBC). Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(4). 119935–119935.

Inoue, Yasumichi, Daisuke Morishita, Hiromasa Aoki, et al.. (2024). ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis. Biochemical and Biophysical Research Communications. 708. 149789–149789. 1 indexed citations

Yamamura, Aya, Yoshiaki Suzuki, Yasumichi Inoue, et al.. (2024). Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension. European Journal of Pharmacology. 973. 176564–176564. 9 indexed citations

Ebara, Shunsuke, et al.. (2024). Interaction of CDK12 with NXF1 is a new node for the linking mechanism between transcription and transportation of mRNA. Biochemical and Biophysical Research Communications. 735. 150608–150608.

Inoue, Yasumichi, Koki Hikami, Shunsuke Ebara, et al.. (2024). Abstract 1233: Novel inhibitor targeting triple integrated stress response kinase HRI, PERK, and GCN2 provides new insights into overcoming resistance to proteasome inhibitors in multiple myeloma. Cancer Research. 84(6_Supplement). 1233–1233. 1 indexed citations

Aoki, Hiromasa, Sumitaka Yamanaka, Daisuke Morishita, et al.. (2024). The Hippo Signaling Pathway Manipulates Cellular Senescence. Cells. 14(1). 13–13. 1 indexed citations

Aoki, Hiromasa, Rina Kato, Yasumichi Inoue, et al.. (2023). The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells. Cancers. 15(3). 735–735. 3 indexed citations

Aoki, Hiromasa, Yasumichi Inoue, Hidetoshi Hayashi, et al.. (2023). AMPK activators suppress cholesterol accumulation in macrophages via suppression of the mTOR pathway. Experimental Cell Research. 432(1). 113784–113784. 5 indexed citations

10.

Aoki, Hiromasa, Hiroki Kakita, Hiroko Ueda, et al.. (2023). The DNMT3B Inhibitor Nanaomycin A as a Neuroblastoma TherapeuticAgent. Current Cancer Drug Targets. 23(11). 837–842. 4 indexed citations

11.

Inoue, Yasumichi, Kan’ichiro Ishiuchi, Michiyo Matsuno, et al.. (2021). Periplocin and cardiac glycosides suppress the unfolded protein response. Scientific Reports. 11(1). 9528–9528. 3 indexed citations

12.

Sakai, Satoshi, Tatsuya Ohhata, Kyoko Kitagawa, et al.. (2019). Long Noncoding RNA ELIT-1 Acts as a Smad3 Cofactor to Facilitate TGFβ/Smad Signaling and Promote Epithelial–Mesenchymal Transition. Cancer Research. 79(11). 2821–2838. 81 indexed citations

13.

Kido, Shinsuke, Itsuro Endo, Daisuke Inoue, et al.. (2010). Mechanical Stress Activates Smad Pathway through PKCδ to Enhance Interleukin-11 Gene Transcription in Osteoblasts. PLoS ONE. 5(9). e13090–e13090. 47 indexed citations

14.

Inoue, Yasumichi, Shun‐ichiro Iemura, Tohru Natsume, Keiji Miyazawa, & Takeshi Imamura. (2010). Suppression of p53 Activity through the Cooperative Action of Ski and Histone Deacetylase SIRT1. Journal of Biological Chemistry. 286(8). 6311–6320. 20 indexed citations

15.

Arima, Yoshimi, Yasumichi Inoue, Tatsuhiro Shibata, et al.. (2008). Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition. Cancer Research. 68(13). 5104–5112. 131 indexed citations

16.

Inoue, Yasumichi, Setsuro Komiya, Kana Horiguchi, et al.. (2008). Smurf2 Induces Ubiquitin-dependent Degradation of Smurf1 to Prevent Migration of Breast Cancer Cells. Journal of Biological Chemistry. 283(51). 35660–35667. 74 indexed citations

17.

Inoue, Yasumichi & Takeshi Imamura. (2008). Regulation of TGF‐β family signaling by E3 ubiquitin ligases. Cancer Science. 99(11). 2107–2112. 211 indexed citations

18.

Inoue, Yasumichi, Hitoshi Tsuda, Issei Imoto, et al.. (2008). SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells. Journal of Biological Chemistry. 284(5). 3334–3344. 72 indexed citations

19.

Morimoto, Koji, Akiko Hamaguchi, Yasumichi Inoue, et al.. (2007). Interaction of cancer cells with platelets mediated by Necl-5/poliovirus receptor enhances cancer cell metastasis to the lungs. Oncogene. 27(3). 264–273. 61 indexed citations

20.

Inoue, Yasumichi, Masatoshi Kitagawa, Kikuo Onozaki, & Hidetoshi Hayashi. (2004). Contribution of the Constitutive and Inducible Degradation of Smad3 by the Ubiquitin-Proteasome Pathway to Transforming Growth Factor- β Signaling. Journal of Interferon & Cytokine Research. 24(1). 43–54. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact